Full Press Release Details
Media Chris Allman-Bradshaw - 336-436-8263
Investors Chas Cook - 336-436-5076
Investor Labcorp.com
LABCORP COMPLETES ACQUISITION OF MYRIAD AUTOIMMUNE'S VECTRA TESTING BUSINESS
BURLINGTON, N.C., Sept. 13, 2021 - Labcorp (NYSE LH), a leading global life sciences company, today announced that it has closed its acquisition of select operating assets and intellectual property (IP) from Myriad Genetics' autoimmune business unit, including the Vectra rheumatoid arthritis (RA) assay. Earlier this year, Labcorp entered into a definitive agreement to acquire Myriad's Vectra test, related IP and other RA assets, bolstering its scientific leadership in rheumatology. Specific terms of the transaction were not disclosed.